Clinical Trials Sponsored by Hematologics, Inc

Total 35742 results

Changi General Hospital
Biofourmis Inc.

Unknown

Kardia - A Smartphone-based Care Model for Outpatient Cardiac Rehabilitation

Post MI

Singapore
Indiana University
Regenstrief Institute, Inc.

Completed

Decreasing Delirium Through Music (DDM)

Delirium

United States
St. Louis University
Epharmix, Inc.

Terminated

Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome

Short Bowel Syndrome

United States
Zimmer Biomet
Biomet Japan, Inc.

Completed

Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System

Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement

Japan
Columbia University
EOS imaging Inc.

Unknown

Value of 3D Modeling in Spine Surgery

Scoliosis

United States
Eisai Co., Ltd.

Completed

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

Japan
Eisai Co., Ltd.

Completed

A Long Term Extension Study of E2080 in Lennox-Gastaut Patients

Lennox-Gastaut Syndrome

Japan
Nabriva Therapeutics AG
Medpace, Inc.

Completed

Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections (ZEUS)

Acute Pyelonephritis | Urinary Tract Infection Complicated | Urinary Tract Infection Symptomatic

Poland, Ukraine, Belarus, Bulgaria, Romania, Greece, United States, Russian Federation, Hungary, Lithuania, Slovakia, Czechia, Latvia, Croatia, Georgia, Estonia
LIB Therapeutics LLC
Medpace, Inc.

Completed

Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

LDL Cholesterol

United States
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome With Constipation | Chronic Constipation

United States, Canada
NYU Langone Health
Genentech, Inc.

Terminated

Tocilizumab for the Treatment of Behcet's Syndrome

Behcet Syndrome

United States
Johnson & Johnson Vision Care, Inc.

Completed

Short-Term Clinical Comparison of Two Silicone Hydrogel Daily Disposable Contact Lenses

Visual Acuity

United Kingdom
Corino Therapeutics, Inc.
Quotient Sciences

Completed

A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

Healthy Volunteers

United Kingdom
Duke University
Intelligent Automation, Inc.

Completed

PrEP for HBCUs (Study 2) (PrEP for HBCUs)

At Risk for HIV

United States
National Health Promotion Associates, Inc.

Completed

Testing a Multilevel Preventive Intervention in Youth Courts

Drug Abuse
Johns Hopkins University
ChiRhoClin, Inc.

Withdrawn

Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis (S-MRCP)

Autoimmune Pancreatitis | Cellular Diagnosis, Pancreatic Cancer

United States
National Health Promotion Associates, Inc.

Unknown

An Evidence-based Approach for Bullying Prevention

Substance Use | Substance Abuse | Cyberbullying | Bullying

United States
Xencor, Inc.
Massachusetts General Hospital

Completed

Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)

IgG4-RD

United States
Taisho Pharmaceutical R&D Inc.

Completed

Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers

Healthy Volunteers

United States
University of Ottawa
NeuroQore Inc.

Completed

NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot Trial

Depressive Disorder, Major

Canada
Johnson & Johnson Vision Care, Inc.

Completed

Biomarker Discovery in Two Daily Disposable Contact Lenses

Visual Acuity

India
Eisai Co., Ltd.

Completed

Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Cellceutix Corporation

Completed

Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers

Psoriasis

United States
Eisai Inc.
Purdue Pharma LP

Completed

Study of Lemborexant-Alcohol Interaction in Healthy Subjects

Healthy Subjects

Canada
Johns Hopkins University
Healthways, Inc.

Withdrawn

A Comprehensive Peer Mentor-based Disease Management Program for Medically Complex Substance Users

Substance Addiction

United States
Mayo Clinic
Marker Therapeutics, Inc.

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Indiana University
Cheetah Medical Inc.

Completed

Non-invasive Cardiac Output Monitor in Young Adults (NICOM)

Fluid Overload | Hypovolemia
Clovis Oncology, Inc.
Novartis Pharmaceuticals

Terminated

Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NOCTURNE)

Autosomal Dominant Polycystic Kidney Disease

United States
Novartis Pharmaceuticals
NantCell, Inc.

Terminated

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

PIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid Tumors

Spain, Belgium, United States, Canada
R-Pharm
Synergy Research Inc.

Completed

Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia

General Anaesthesia

Russian Federation
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Alzheimer's Desease

Japan
Rebiscan, Inc.
University of Pennsylvania

Completed

HITT Device Pilot Testing for Traumatic Brain Injury

Brain Injuries, Traumatic

United States
Eisai Co., Ltd.

Completed

Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Breast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast Cancer

China
Eisai Co., Ltd.

Completed

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

Gastric Ulcer | Duodenal Ulcer

Japan
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
BioQ Pharma, Inc.
Health Decisions

Completed

Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery

Pain, Postoperative

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

Chronic Kidney Disease | Autosomal Dominant Polycystic Kidney Disease

Australia, Belgium, Italy, Spain, Sweden, United States, Canada, Netherlands, Czechia, Poland, Germany, Russian Federation, Hungary, Israel, Puerto Rico, Argentina, Denmark, South Africa, United Kingdom, Norway, France, Romania
Incheon St.Mary's Hospital
Ybrain Inc.

Completed

Study of tDCS for Mild Cognitive Impairment

Mild Cognitive Impairment

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...

Completed

Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) (OSMITTER)

Device Latency

United States
NIZO Food Research
PanTheryx, Inc.

Completed

PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli (APA12/PANTER)

Traveler's Diarrhea

Netherlands
UCB BIOSCIENCES, Inc.

Completed

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Partial Epilepsies | Partial Onset Seizures

United States
UCB BIOSCIENCES, Inc.

Completed

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Epilepsy

United States
Eisai Co., Ltd.

Completed

Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.

Breast Cancer | HER2-negative Breast Cancer

Japan
Kaiser Permanente
TaiMed Biologics Inc.

Completed

Investigator-Sponsored Protocol - Continued Use of Ibalizumab

HIV Infections

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of Fitting Investigational Contact Lenses

Visual Acuity

United States
Johnson & Johnson Vision Care, Inc.

Completed

Evaluation of Etafilcon A Daily Disposable Lenses

Myopia

United States
Johnson & Johnson Vision Care, Inc.

Completed

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

Myopia

United States
Johnson & Johnson Vision Care, Inc.

Completed

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Refractive Ametropia

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical and Laboratory Evaluation of 3 Contact Lenses With 4 Contact Lens Solutions

Contact Lens Solutions

United States, Canada, United Kingdom

Clinical Trials Sponsored by Hematologics, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations